Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
Building the Science of Evidence-Informed Prevention Policy: a Multi-level Model for Supporting Substance Misuse Prevention
2 other identifiers
interventional
300
1 country
1
Brief Summary
If science is to inform effective substance misuse prevention policy and ultimately improve public health, the field needs an effective strategy for directly supporting policymakers' use of research evidence, yet our field lacks an evidence-based model designed for this purpose. Accordingly, a state-level randomized controlled trial (N = 30 states) of a formal, theory-based approach for appropriately supporting policymakers' use of scientific evidence--known as the Research-to-Policy Collaboration (RPC) Model is proposed. This work has the potential to reduce population-level substance misuse by improving the use of scientific information in policymaking, thus increasing the availability of evidence-based prevention programs and policies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
February 19, 2025
CompletedFirst Posted
Study publicly available on registry
March 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
March 6, 2025
March 1, 2025
4 years
February 19, 2025
March 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RPC impact on introduction of evidence-informed bills
Assessment of use of research evidence in bills introduced during the intervention period. It is anticipated that legislators will introduce over 5,000 bills relating to substance use are. These bills will be coded for presence of evidence markers using a validated, deductive codebook to identify how legislators use research evidence in legislative language. A subset of these bills (N = 150) will be reviewed by trained coders to identify the form (i.e. direct or indirect) and the goal of evidence use (i.e., sharing the cause of the problem, status of the problem, solving the problem, generating new knowledge, or accountability). Observed use of research evidence in bills will be quantified and analyzed in a series of multi-level models to test change across three time points.
Baseline, post intervention, and 6-months post intervention
Secondary Outcomes (4)
RPC impact on legislators' perceived use of prevention research
Baseline, post intervention, and 6 months post-intervention
RPC impact on legislators' engagement with prevention researchers
Baseline, post collaboration, and 6 months post-intervention
RPC impact on state legislators' value of substance misuse prevention science
Baseline, post intervention, and 6 months post intervention
RPC effectiveness on legislators' awareness of substance misuse prevention science
Baseline, post intervention, and 6 months post-intervention
Study Arms (2)
Intervention Group
EXPERIMENTALLegislative offices who receive the full Research-to-Policy Model intervention.
Control Group
ACTIVE COMPARATORLegislative Offices who do not receive the full RPC Model intervention.
Interventions
The RPC model entails seven interrelated steps including a capacity building and collaboration phase. Throughout the implementation, researchers are provided direct access to intermediary support from our trained RPC fellows who facilitate RPC activity at each step coordinated by an implementation supervisor. Importantly, this model does not involve any lobbying. Consistent with NIH guidelines for grantees, the RPC instead aims to "highlight and translate public health evidence…; conduct coalition building…; provide leadership and training, and foster safe and healthful environments". Specifically, implementation of the RPC model explicitly does not attempt to influence legislative actions, but instead facilitates honest brokerage in which researchers discuss evidence without indicating opinion or stance on how legislators should change specific policies, programs, or regulations.
Control group participants will receive "light touch" research support, similar to previous work (e.g., an RPC associate will send publicly available research materials in response to research requests). This light touch control condition will increase responsiveness of state officials to survey follow up requests.
Eligibility Criteria
You may qualify if:
- State-level public officials
You may not qualify if:
- Anyone who is not a state-level public official
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Penn State Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Penn State University
University Park, Pennsylvania, 16802, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Human Development and Family Studies
Study Record Dates
First Submitted
February 19, 2025
First Posted
March 4, 2025
Study Start
April 1, 2023
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
March 6, 2025
Record last verified: 2025-03